As we approach the end of 2023, investors and stakeholders are keeping a close watch on financial updates from major global companies. One such update that has garnered attention is from Philip Morris International, the tobacco industry giant, which recently reaffirmed its financial guidance for 2024.
Philip Morris: A Snapshot of a Tobacco Titan
Philip Morris International is a global leader in the tobacco sector, with its well known brand portfolio including Marlboro, L&M, and Chesterfield. Recently, the company has been focusing on a strategic shift towards Reduced Risk Products, such as IQOS and IQOS ILUMA, aiming to lead the charge in the industry’s transformation. This shift is significant, with RRPs now accounting for more than 32% of PMI's total net revenue as of 2023, compared to just 16% in 2018. PMI's commitment to a "smoke free future" is a key driver behind its evolving strategy, and this shift is reflected in its latest financial guidance for 2024.
Key Figures from the 2024 Financial Guidance
Philip Morris International has confirmed its financial outlook for 2024, providing important figures that investors need to understand. Let’s break down the numbers:
Revenue Growth Forecast: PMI projects a net revenue growth of 5% to 7% on an organic basis for 2024. In monetary terms, this would translate to an increase of approximately $4 billion from 2023’s projected revenues of around $80 billion. The revenue growth is expected to be driven by the continued success of IQOS, expansion into new markets, and higher pricing power across traditional cigarette brands.
Earnings Per Share (EPS) Growth: The company confirmed its adjusted diluted EPS growth target of 8% to 10% on a currency neutral basis. PMI’s adjusted EPS in 2023 is expected to be between $6.05 to $6.15. The forecasted growth could push the EPS range to between $6.53 to $6.77 by the end of 2024. This solid EPS growth is crucial for evaluating the company’s profitability.
Adjusted Operating Income Margin: PMI expects to achieve an adjusted operating income margin expansion of 150 to 200 basis points in 2024. This margin improvement is attributed to the favourable product mix towards higher margin RRPs and ongoing cost optimisation measures. As of 2023, PMI's adjusted operating income margin stands at around 45%, which means it could rise to around 47% in 2024.
Free Cash Flow: PMI forecasts a robust free cash flow of around $10 billion for 2024, up from an estimated $9.5 billion in 2023. This anticipated growth in free cash flow is significant, as it underpins PMI's ability to continue rewarding shareholders through dividends and share buybacks.
Capital Expenditures and Investment in RRPs: The company plans to allocate approximately $1 billion in capital expenditures for 2024, with a significant portion directed towards research and development and marketing for its RRPs. PMI's R&D spending, which currently stands at around $350 million annually, is expected to increase by 10-15% as part of its investment strategy.
Dividend Payout: PMI has a strong track record of returning capital to shareholders through dividends. For 2024, the company aims to maintain a dividend payout ratio of approximately 75% of its adjusted net earnings, which could result in a dividend yield of about 5-6%, based on the current stock price. In 2023, PMI's dividend was $5.16 per share, and with expected EPS growth, this figure could increase to around $5.50 to $5.60 in 2024.
What Do These Figures Mean for Investors?
We know that numbers are only half the story; understanding their implications for your investments is key. Here are the important takeaways:
Potential for Revenue Growth: With an organic revenue growth projection of 5% to 7%, PMI is positioning itself for steady expansion. The increasing contribution of RRPs to total revenues expected to reach around 40% by 2024 shows a clear trajectory towards growth in this segment.
Stable Earnings with a Strong Growth Trajectory: The adjusted EPS growth target of 8% to 10% indicates robust profitability even in a challenging economic environment. Given that PMI has consistently met or exceeded its EPS guidance over the last five years, this bodes well for investors looking for steady returns.
Solid Free Cash Flow Supports Dividends and Buybacks: With an expected free cash flow of $10 billion, PMI is well positioned to continue its shareholder friendly policies. For income focused investors, the combination of solid EPS growth, a high dividend payout ratio, and potential share buybacks provides a compelling case for holding PMI shares.
Long-Term Investment in Reduced Risk Products: PMI’s commitment to RRPs is evident, with an increasing share of its capital expenditures devoted to this segment. The company expects RRP users to exceed 40 million by the end of 2024, up from 29 million in 2023. This focus on future growth aligns with a long term investment strategy, making PMI a potentially rewarding option for growth oriented investors.
Potential Risks to Monitor
While PMI’s guidance is optimistic, investors should remain mindful of several potential risks:
Regulatory and Legal Risks: The tobacco industry remains one of the most regulated sectors globally. New regulations in key markets like the US, EU, and Asia could bring significant challenges. PMI faces ongoing legal battles and the potential for increased excise taxes, which could impact its margins.
Currency Fluctuations: While PMI provides a currency neutral outlook, adverse currency movements, especially in emerging markets like Brazil, Indonesia, and Russia, could impact actual results. A 5% devaluation in the US dollar could reduce EPS by about $0.10.
Competitive Pressure in RRPs: As more companies enter the Reduced Risk Products space, PMI faces intense competition. While IQOS leads the heated tobacco market with a global share of 80%, competition from companies like British American Tobacco and Japan Tobacco could pressure market share and margins.
Why Philip Morris Remains a Strong Choice for 2024
Despite potential risks, we see Philip Morris as a strong investment candidate for 2024 and beyond. Here’s why:
Dominant Market Position: PMI’s strength in both traditional tobacco and RRPs allows it to capture revenue from a broad consumer base. Its dominance in key markets ensures a steady cash flow, even amidst regulatory and economic challenges.
Consistent Strategic Execution: PMI’s clear focus on transforming its business model towards a smoke free future is not just news. With over $10 billion invested in RRP innovation since 2008, it’s clear the company is committed to sustainable, long term growth.
Attractive Valuation and Dividends: With a forward P/E ratio of around 15x, PMI is attractively valued relative to its peers. Coupled with a robust dividend yield, it offers both income and growth potential.
Philip Morris International’s confirmation of its financial guidance for 2024 reflects a confident outlook. With strong revenue and EPS growth, increasing investment in Reduced Risk Products, and a commitment to rewarding shareholders, PMI is positioned as a compelling investment for those seeking stability, growth, and income.
Content on IceburgWealth.com is for informational purposes only and not intended as investment advice. While we strive to provide accurate and up-to-date information, Iceburg Wealth is not responsible for any errors or omissions, or for outcomes resulting from the use of this information. Readers should seek professional advice before making any financial decisions.